Diabetes news and diabetes widget

Researchers from Ben-Gurion University of the Negev (BGU) in Beer-Sheva, Israel have demonstrated that treating diabetic animals with alpha-1-antitrypsin (AAT) following an islet transplantation procedure eliminates the inflammation that causes islet transplants to fail. (PNAS Article #08-07627: "Alpha-1-Antitrypsin Monotherapy Induces Immune Tolerance during Islet Allograft Transplantation in Mice") (

Researchers from Ben-Gurion University of the Negev (BGU) in Beer-Sheva, Israel have demonstrated that treating diabetic animals with alpha-1-antitrypsin (AAT) following an islet transplantation procedure eliminates the inflammation that causes islet transplants to fail. (PNAS Article #08-07627: "Alpha-1-Antitrypsin Monotherapy Induces Immune Tolerance during Islet Allograft Transplantation in Mice") (

For his milestone discoveries on the development of diabetes, Prof. Markus Stoffel from the Institute of Molecular Systems Biology at the ETH Zurich was today awarded the Heinrich Wieland Prize, one of the most treasured science awards in Germany. He received the distinction with EUR 50,000 prize money for his work in deciphering important mechanisms of blood sugar regulation and lipid metabolism in the body.

Investigators combing the genome in the hope of finding genetic variants responsible for triggering early-onset diabetes may be looking in the wrong place, new research at the Stanford University School of medicine suggests. Early-onset diabetes, also known as type-1 diabetes, is an autoimmune disease, caused when the immune system attacks and destroys insulin-producing cells in a person's pancreas.

Bayhill Therapeutics, Inc., a leading developer of therapies for autoimmune diseases, and the Juvenile diabetes Research Foundation, the world's leading charitable funder of type 1 diabetes research, today announced a partnership to support Bayhill's ongoing Phase I/II human clinical trial of BHT-3021, a DNA vaccine to reverse the immune response that causes type 1 diabetes.

Researchers conducting a meta-analysis of studies related to the diabetes medication metformin have found that the drug may be linked to a lower risk of death from cardiovascular disease. The study, which appears in the October 27 issue of Archives of Internal medicine, did not find any other associations between diabetes medications and positive or negative cardiovascular effects - but frequently because the necessary data were unavailable.

Research shows that proprietary non-brain penetrant cannabinoid subtype 1 (CB1) receptor antagonists developed by Jenrin Discovery are able to produce metabolically favorable effects in peripheral tissues, including fat and liver.

HealthDay - FRIDAY, Oct. 31 (HealthDay News) -- The more weight a woman gains during pregnancy, the more likely she is to have a large baby, posing health risks to both mother and child, a new study finds.

Whether your tastes tend toward bright lights and big cities, quiet contemplation or off-road racing, groups around the U.S. are gearing up to celebrate World diabetes Day and raise awareness of the growing threat of diabetes.

As one of the most common chronic conditions, diabetes affects nearly 24 million Americans and occurs when the body fails to process sugar correctly. Left untreated, diabetes can affect one's vision, in some cases even causing blindness, due to changes in the blood vessels of the retina. Almost 41% of adults aged 40 and older with diabetes have an eye disease that is known as diabetic retinopathy.